Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression-Reference-Cited by-同舟云学术

Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression

Published:2003-02 Issue:2 Volume:27 Page:133-145
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Stirewalt D.L.,Appelbaum F.R.,Willman C.L.,Zager R.A.,Banker D.E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference54 articles.

1. Regulation of the mevalonate pathway;Goldstein;Nature,1990

2. Eisenberg DA. Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials (review). Am J Med 1998;104(2A):2S–5S; Rudling M, Gåfvels M, Parini P, Gahrton G, Angelin B. Lipoprotein receptors in acute myelogenous leukemia. Am J Pathol 1998;153:1923–1935.

3. Suppression of murine neuroblastoma growth in vivo by mevilonin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase;Maltese;J. Clin. Invest.,1985

4. Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and phenylacetate against glioma cells;Prasanna;J. Neurochem.,1996

5. Effect of cholesterol-free diet and hypocholestrolemic agents on the growth of transplantable animal tumors;Littman;Cancer Chem. Rep.,1966

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatic analysis reveals cancer-associated lysine gene signatures as a poor prognostic factor and potential therapeutic target in esophageal squamous cell carcinoma;2023-11-21

2. Lipid metabolism as a target for cancer drug resistance: progress and prospects;Frontiers in Pharmacology;2023-09-28

3. Lipid metabolic vulnerabilities of multiple myeloma;Clinical and Experimental Medicine;2023-08-28

4. Targeting cholesterol homeostasis in hematopoietic malignancies;Blood;2022-01-13

5. Genome-scale integration of transcriptome and metabolome unveils squalene synthase and dihydrofolate reductase as targets against AML cells resistant to chemotherapy;COMPUT STRUCT BIOTEC;2021